Asian Multinational Phase II Study of Darinaparsin in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
Background: Darinaparsin is a novel organic arsenic compound composed of dimethylated arsenic linked to glutathione. In two phase I studies including Japanese and Korean patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), darinaparsin was well tolerated and demonstrated potential...
Saved in:
Published in | Blood Vol. 138; no. Supplement 1; p. 1376 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
23.11.2021
|
Online Access | Get full text |
ISSN | 0006-4971 1528-0020 |
DOI | 10.1182/blood-2021-145512 |
Cover
Loading…